Brief: 180 Life Sciences Corp Scheduled Meeting During Q4 2022 With MHRA Regarding its Phase 2B Data In Dupuytren’S Disease
26/09/2022 13:56
Sept 26 (Reuters) - 180 Life Sciences Corp ATNF.O :
* 180 LIFE SCIENCES CORP - SCHEDULED MEETING DURING Q4 2022
WITH
MHRA REGARDING OUR PHASE 2B DATA IN DUPUYTREN’S DISEASE
* 180 LIFE SCIENCES CORP - WE EXPECT TO GAIN CLARITY FROM
THE MHRA
BY LATE FIRST QUARTER OF 2023
Further company coverage: ATNF.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Forum Markets
See all newsForum Markets, Inc reports results for the quarter ended June 30 - Earnings Summary
Forum Markets Q2 revenue falls on digital asset exit
Forum Markets, Inc expected to post a loss of 26 cents a share - Earnings Preview
Forum Markets, Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: Forum Markets, Inc - To Deploy Capital Into Ai Chip Bridge Loans For Nvidia Gpu Purchases